Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 28664 [2018-13231]

Download as PDF 28664 Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 20, 2018. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of SUPPLEMENTARY INFORMATION: manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March 13, 2018, American Radiolabeled Chem, 101 Arc Drive, St. Louis, MO 63146 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Gamma Hydroxybutyric Acid ................................................................................................................................... Ibogaine ................................................................................................................................................................... Lysergic acid diethylamide ...................................................................................................................................... Tetrahydrocannabinols ............................................................................................................................................ Dimethyltryptamine .................................................................................................................................................. 1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... Dihydromorphine ...................................................................................................................................................... Heroin ...................................................................................................................................................................... Normorphine ............................................................................................................................................................ Amphetamine ........................................................................................................................................................... Methamphetamine ................................................................................................................................................... Amobarbital .............................................................................................................................................................. Phencyclidine ........................................................................................................................................................... Phenylacetone ......................................................................................................................................................... Cocaine .................................................................................................................................................................... Codeine .................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................ Oxycodone ............................................................................................................................................................... Hydromorphone ....................................................................................................................................................... Ecgonine .................................................................................................................................................................. Hydrocodone ............................................................................................................................................................ Meperidine ............................................................................................................................................................... Metazocine ............................................................................................................................................................... Methadone ............................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... Morphine .................................................................................................................................................................. Oripavine .................................................................................................................................................................. Thebaine .................................................................................................................................................................. Oxymorphone .......................................................................................................................................................... Phenazocine ............................................................................................................................................................ Carfentanil ................................................................................................................................................................ Fentanyl ................................................................................................................................................................... The company plans to manufacture small quantities of the above-listed controlled substances as radiolabeled compounds for biochemical research. Dated: June 12, 2018. John J. Martin, Assistant Administrator. sradovich on DSK3GMQ082PROD with NOTICES [FR Doc. 2018–13231 Filed 6–19–18; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 20, 2018. DATES: VerDate Sep<11>2014 17:58 Jun 19, 2018 Jkt 244001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: DEPARTMENT OF JUSTICE ACTION: 2010 7260 7315 7370 7435 7470 9145 9200 9313 1100 1105 2125 7471 8501 9041 9050 9120 9143 9150 9180 9193 9230 9240 9250 9273 9300 9330 9333 9652 9715 9743 9801 Schedule The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, SUPPLEMENTARY INFORMATION: E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)]
[Notices]
[Page 28664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13231]



[[Page 28664]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: American 
Radiolabeled Chem

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 20, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on March 
13, 2018, American Radiolabeled Chem, 101 Arc Drive, St. Louis, MO 
63146 applied to be registered as a bulk manufacturer of the following 
basic classes of controlled substances:

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............            2010               I
Ibogaine................................            7260               I
Lysergic acid diethylamide..............            7315               I
Tetrahydrocannabinols...................            7370               I
Dimethyltryptamine......................            7435               I
1-[1-(2-Thienyl)cyclohexyl]piperidine...            7470               I
Dihydromorphine.........................            9145               I
Heroin..................................            9200               I
Normorphine.............................            9313               I
Amphetamine.............................            1100              II
Methamphetamine.........................            1105              II
Amobarbital.............................            2125              II
Phencyclidine...........................            7471              II
Phenylacetone...........................            8501              II
Cocaine.................................            9041              II
Codeine.................................            9050              II
Dihydrocodeine..........................            9120              II
Oxycodone...............................            9143              II
Hydromorphone...........................            9150              II
Ecgonine................................            9180              II
Hydrocodone.............................            9193              II
Meperidine..............................            9230              II
Metazocine..............................            9240              II
Methadone...............................            9250              II
Dextropropoxyphene, bulk (non-dosage                9273              II
 forms).................................
Morphine................................            9300              II
Oripavine...............................            9330              II
Thebaine................................            9333              II
Oxymorphone.............................            9652              II
Phenazocine.............................            9715              II
Carfentanil.............................            9743              II
Fentanyl................................            9801              II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical 
research.

    Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-13231 Filed 6-19-18; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.